Inceptive
Palo Alto
About Inceptive
Inceptive designs RNA molecules using large-scale deep learning in a tight loop with high-throughput experiments. They create tools to develop increasingly powerful biological software for the rational design of novel, broadly accessible medicines and biotechnologies previously out of reach.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $120.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2023)
- Website: inceptive.life
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/inceptive-49545 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.